A detailed history of Epoch Investment Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 1,867,744 shares of PFE stock, worth $51.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,867,744
Previous 1,908,476 2.13%
Holding current value
$51.3 Million
Previous $53 Million 1.32%
% of portfolio
0.25%
Previous 0.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $1.03 Million - $1.21 Million
-40,732 Reduced 2.13%
1,867,744 $52.3 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $3.25 Million - $3.73 Million
-125,520 Reduced 6.17%
1,908,476 $53 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $23.6 Million - $30.7 Million
-903,333 Reduced 30.75%
2,033,996 $58.6 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $305,079 - $356,607
9,507 Added 0.32%
2,937,329 $97.4 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $4.05 Million - $4.69 Million
112,113 Added 3.98%
2,927,822 $107 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $10.2 Million - $13.3 Million
260,153 Added 10.18%
2,815,709 $115 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $1.54 Million - $2.01 Million
-36,825 Reduced 1.42%
2,555,556 $131 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $6.44 Million - $7.86 Million
-147,213 Reduced 5.37%
2,592,381 $113 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $7.45 Million - $8.83 Million
-160,101 Reduced 5.52%
2,739,594 $144 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $9.95 Million - $12.3 Million
217,580 Added 8.11%
2,899,695 $150 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $33.3 Million - $49.3 Million
-804,761 Reduced 23.08%
2,682,115 $158 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $9.89 Million - $12.7 Million
-252,027 Reduced 6.74%
3,486,876 $150 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $20.2 Million - $22.9 Million
-562,299 Reduced 13.07%
3,738,903 $146 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $202,380 - $228,244
-6,043 Reduced 0.14%
4,301,202 $156 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $6.2 Million - $7.89 Million
-185,360 Reduced 4.13%
4,307,245 $159 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $18.8 Million - $22.1 Million
-592,056 Reduced 11.64%
4,492,605 $165 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $161 Million - $195 Million
-5,346,317 Reduced 51.25%
5,084,661 $166 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $8.98 Million - $12.8 Million
332,206 Added 3.29%
10,430,978 $340 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $7.93 Million - $9 Million
241,033 Added 2.45%
10,098,772 $396 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $29.8 Million - $38.7 Million
918,229 Added 10.27%
9,857,739 $354 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $24.6 Million - $27.6 Million
-665,507 Reduced 6.93%
8,939,510 $387 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $4.74 Million - $5.21 Million
126,346 Added 1.33%
9,605,017 $408 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $39.9 Million - $45.5 Million
-1,036,313 Reduced 9.86%
9,478,671 $414 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $63.8 Million - $77.4 Million
-1,851,726 Reduced 14.97%
10,514,984 $463 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $22.2 Million - $23.7 Million
-673,903 Reduced 5.17%
12,366,710 $449 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $20.4 Million - $23.6 Million
638,648 Added 5.15%
13,040,613 $463 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $4.56 Million - $4.84 Million
-137,033 Reduced 1.09%
12,401,965 $449 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $389 Million - $428 Million
12,538,998
12,538,998 $448 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.